Erez Raphael - 12 Aug 2024 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: DRIO
Reported as of: 12 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Sep 2026, 16:05:13 UTC
Prior SEC filing: 08 Mar 2024
Next SEC filing: 20 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Erez Raphael

Key filing fact

Erez Raphael filed Form 4 for DarioHealth Corp. (DRIO) on 28 Sep 2026.

Key facts

This page summarizes Erez Raphael's Form 4 filing for DarioHealth Corp. (DRIO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Sep 2026, 16:05.

Change

Previous filing in this sequence was filed on 08 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001668046 Primary reporting owner

Raphael Erez

Relationship: Chief Executive Officer, Director
Address: 322 W 57TH STREET, #33B, NEW YORK
Signature: /s/ Erez Raphael
Signature date: 28 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRIO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +579
Change %: +0.37%
Price: $19.10^*
Shares after: 157,432
Date: 12 Aug 2024
Ownership: Direct
Footnotes: F1, F2

DRIO transaction

Common Stock

Award

Transaction value
Shares: +297,000
Change %: +189%
Price: $0.000000^*
Shares after: 454,432
Date: 24 Sep 2026
Ownership: Direct
Footnotes: F3

DRIO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,894
Date: 12 Aug 2024
Ownership: By Dicilyon Consulting and Investment Ltd.

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DRIO transaction Derivative

Series B-2 Preferred Stock

Conversion of derivative security

Transaction value
Shares: -30
Change %: -100%
Price: $1000.00^*
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 579
Exercise price: $1000.00

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.

Footnote F2

The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion.

Footnote F3

The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.